by Instem Team | Aug 4, 2026 | Clinical
Life sciences organizations face a difficult balancing act: protecting patient privacy, meeting evolving global clinical trial transparency requirements, and maintaining sufficient data utility to support meaningful research. At the same time, clinical datasets and...
by Instem Team | Aug 4, 2026 | In Silico & Data Insights
Many impurities are evaluated through systemic toxicity endpoints, where acceptable exposure limits can be derived from repeat-dose studies and other toxicological data. Before such evaluations can proceed, however, the potential for mutagenicity is typically...
by Instem Team | Aug 3, 2026 | Resources
Computational toxicology solutions for chemical safety assessment across a broad range of toxicological endpoints, combining curated experimental data, transparent predictive models, mechanistic knowledge, and structural analysis tools within an integrated workflow....
by Instem Team | Jul 28, 2026 | Resources
Clinical development is becoming increasingly data-intensive, placing greater demands on Statistical Computing Environments (SCEs). Legacy platforms can create operational bottlenecks, increase validation effort, and make it more difficult to support modern analytics...
by Instem Team | Jul 28, 2026 | Resources
Modern labs rely on a wide range of instruments, workstations, databases, local drives, SharePoint sites, and legacy systems, each of which may generate or store regulated data differently. These platforms are often geographically distributed, and even individually...
